Wei E. Wang
Expertise in
84
conditions

Dr. Wei E. Wang

Psychiatry
35 W Hudson Ave, 
Englewood, NJ 
Accepting New Patients
Expertise in
84
conditions
35 W Hudson Ave, 
Englewood, NJ 

Overview

Wei Wang is a Psychiatrist practicing medicine in Englewood, New Jersey.

Dr. Wang is highly rated in 84 conditions, according to our data. Her clinical expertise encompasses Gallbladder Disease, Dementia, Ocular Hypertension (OHT), Bone Marrow Aspiration, and Endoscopy.

She is actively involved in clinical research, co-authoring 20733 peer reviewed articles and participating in 7 clinical trials. Dr. Wang is currently accepting new patients.

Specialties

Psychiatry

Licenses

Psychiatry & Neurology in NY

Hospital Affiliations

Hunterdon Medical Center

Languages Spoken

English
Mandarin

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Capital District Physicians Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Clover Health
  • INSURANCE PLAN
  • MEDICARE MAPD
EmblemHealth
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
Health First
  • HMO
  • POS
Highmark
  • EPO
  • HMO
  • PPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
MetroPlus Health
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE-MEDICAID PLAN
MVP Health
  • EPO
  • PPO
Oscar
  • EPO
  • HMO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 16 Less Insurance Carriers -

Locations

35 W Hudson Ave, Englewood, NJ 07631
Other Locations
HUNTERDON SPECIALTY CARE
2100 Wescott Dr, Flemington, NJ 08822
HUNTERDON SPECIALTY CARE
1251 Route 22, Bridgewater, NJ 08807

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

A Phase IB Study of Safety, Efficacy and Pharmacokinetic of Intravenously Administered Pelcitoclax (APG-1252) in Patients With Advanced Neuroendocrine Tumor
A Phase IB Study of Safety, Efficacy and Pharmacokinetic of Intravenously Administered Pelcitoclax (APG-1252) in Patients With Advanced Neuroendocrine Tumor
Enrollment Status: Terminated
Publish Date: April 17, 2025
Intervention Type: Drug
Study Drug: Pelcitoclax
Study Phase: Phase 1
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Pamrevlumab in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Pamrevlumab in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
Enrollment Status: Terminated
Publish Date: September 19, 2024
Intervention Type: Drug
Study Drug: Pamrevlumab
Study Phase: Phase 3
Zephyrus II: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Pamrevlumab in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
Zephyrus II: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Pamrevlumab in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
Enrollment Status: Terminated
Publish Date: August 12, 2024
Intervention Type: Drug
Study Drug: Pamrevlumab
Study Phase: Phase 3
Diagnostic and Monitoring Significance of Circulating Tumor DNA (ctDNA) Methylation Analysis by Next-Generation Sequencing in Benign and Malignant Pulmonary Nodules
Diagnostic and Monitoring Significance of Circulating Tumor DNA (ctDNA) Methylation Analysis by Next-Generation Sequencing in Benign and Malignant Pulmonary Nodules
Enrollment Status: Unknown
Publish Date: May 24, 2023
Intervention Type: Diagnostic test
A Prospective Cohort Study of Predictors and Prognostic Factors on the Acute Ischemic Stroke
A Prospective Cohort Study of Predictors and Prognostic Factors on the Acute Ischemic Stroke
Enrollment Status: Terminated
Publish Date: December 07, 2022
Intervention Type: Other, Drug, Diagnostic test
Megestrol Acetate for the Improvement of Quality of Life in Esophageal Cancer With Chemoradiotherapy
Megestrol Acetate for the Improvement of Quality of Life in Esophageal Cancer With Chemoradiotherapy
Enrollment Status: Completed
Publish Date: February 17, 2021
Intervention Type: Drug, Radiation, Other
Study Phase: Phase 3
Caffeic Acid for Advanced Esophageal Squamous Cell Cancer: A Randomized, Double-blind, and Multicenter Trial in Chinese Patients
Caffeic Acid for Advanced Esophageal Squamous Cell Cancer: A Randomized, Double-blind, and Multicenter Trial in Chinese Patients
Enrollment Status: Unknown
Publish Date: November 27, 2020
Intervention Type: Drug
Study Drug: Caffeic Acid
Study Phase: Phase 3
View 6 Less Clinical Trials

20671 Total Publications

How the discovery of mammalian regeneration shapes translational efforts.
How the discovery of mammalian regeneration shapes translational efforts.
Journal: Nature reviews. Molecular cell biology
Published: August 13, 2026
Similar Doctors
Expertise in
1
conditions
Expertise in
1
conditions
Referral may be required

NYU Langone Psychiatry Associates

1 Park Ave Fl 8, 
New York, NY 
 (11.4 miles away)
212-263-3580
Languages Spoken:
English
See accepted insurances

Lenard Adler is a Psychiatrist practicing medicine in New York, New York. Dr. Adler is highly rated in 1 condition, according to our data. His clinical expertise encompasses Attention Deficit Hyperactivity Disorder (ADHD).

Expertise in
1
conditions
Expertise in
1
conditions
Referral may be required

Veterans Affairs New York Harbor Healthcare System-Manhattan Campus

423 E 23rd St, 
New York, NY 
 (12.0 miles away)
212-951-3294
Languages Spoken:
English

John Rotrosen is a Psychiatrist practicing medicine in New York, New York. Dr. Rotrosen is highly rated in 1 condition, according to our data. His clinical expertise encompasses Opioid Use Disorder.

Expertise in
5
conditions
Expertise in
5
conditions
Referral may be required

Office

18 Beach Ave, 
Larchmont, NY 
 (11.4 miles away)
914-833-1493
Languages Spoken:
English
See accepted insurances

Antony Loebel is a Psychiatrist practicing medicine in Larchmont, New York. Dr. Loebel is highly rated in 5 conditions, according to our data. His clinical expertise encompasses Bipolar Disorder (BPD), Schizophrenia, Major Depression, and Schizoaffective Disorder.

Frequently Asked Questions about Dr. Wei E. Wang

How do I make an appointment with Dr. Wei E. Wang?

You can book an appointment with Dr. Wei E. Wang by calling their office at 201-408-4487. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Wei E. Wang a top-rated expert for Bone Marrow Aspiration?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Wei E. Wang is classified as an Elite expert for Bone Marrow Aspiration, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Wei E. Wang specialize in?

While Dr. Wei E. Wang is a Psychiatry, they have specific expertise in Bone Marrow Aspiration, Endoscopy, and Gallbladder Disease. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Psychiatry.

Does Dr. Wei E. Wang participate in research or clinical trials?

Yes. Dr. Wei E. Wang has published 20671 articles and abstracts on conditions like Bone Marrow Aspiration. You can view a list of Dr. Wei E. Wang's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Wei E. Wang accept my insurance?

Dr. Wei E. Wang accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 201-408-4487 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Wang's expertise for a condition
ConditionClose
View All 35 Distinguished Conditions
View All 46 Advanced Conditions
View All 59 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile